๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

The effect of mirtazapine add on therapy to risperidone in the treatment of schizophrenia: A double-blind randomized placebo-controlled trial

โœ Scribed by Seyed-Hesameddin Abbasi; Haleh Behpournia; Aboulfazl Ghoreshi; Bahman Salehi; Maedeh Raznahan; Shams-Ali Rezazadeh; Farzin Rezaei; Shahin Akhondzadeh


Book ID
119364391
Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
415 KB
Volume
116
Category
Article
ISSN
0920-9964

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Mirtazapine add-on therapy in the treatm
โœ Michael Berk; Clarissa S. Gama; Suresh Sundram; Harry Hustig; Les Koopowitz; Rus ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 78 KB ๐Ÿ‘ 1 views

## Abstract ## Objective Schizophrenia is a multifaceted illness with positive, negative and cognitive symptom domains. Standard treatments often focus on positive symptoms and may not adequately relieve other symptoms. Previous studies have suggested a role for mirtazapine in schizophrenia, parti

Efficacy of selegiline add on therapy to
โœ Afshar Amiri; Ahmad-Ali Noorbala; Ali-Akbar Nejatisafa; Abolfazl Ghoreishi; Moha ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 100 KB

## Abstract ## Objective It has been reported that selegiline, a Selective Monoamine Oxidase Inhibitor B (MAOIโ€B), at low doses would be helpful for treating negative symptoms in schizophrenia. Nevertheless, the results are contradictory so far. This study was designed to investigate the effect of